Therefore, for CBAVD patients, it is necessary to conduct genetic counseling and detection to determine whether there is a pathogenic CFTR mutation and the risk degree of passing it to offspring. The gene discussed is CFTR; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.